Chargement en cours...
Surfactants in the Management of Respiratory Distress Syndrome in Extremely Premature Infants
Respiratory distress syndrome (RDS) is primarily due to decreased production of pulmonary surfactant, and it is associated with significant neonatal morbidity and mortality. Exogenous pulmonary surfactant therapy is currently the treatment of choice for RDS, as it demonstrates the best clinical and...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Pediatric Pharmacy Advocacy Group
2006
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3468090/ https://ncbi.nlm.nih.gov/pubmed/23118650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-11.3.132 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|